Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-01 Sale | 2026-10-07 4:09 pm | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 24,655 | $5 | $123,275 | 47,682 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-18 Tax Withholding | 2026-09-23 8:32 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 82,527 | $5.07 | 327,595 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:32 pm | N/A 2035-03-18 | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 126,864 | $0 | 327,595 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:32 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 116,408 | $3.2 | 327,595 (Direct) | View |
| 2026-09-18 Exercise | 2026-09-23 8:32 pm | N/A N/A | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 10,456 | $4.39 | 327,595 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-02 8:21 pm | N/A 2036-02-02 | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 99,700 | $0 | 99,700 (Direct) | View |
| 2025-03-18 Option Award | 2025-03-20 4:08 pm | N/A 2035-03-18 | Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO | 310,422 | $0 | 310,422 (Direct) | View |
| 2025-01-24 Exercise | 2025-01-28 5:35 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 3,750 | $0 | 19,500 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-17 4:01 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:32 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-31 4:07 pm | N/A 2033-01-30 | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 2,859 | $0 | 2,859 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 9:50 pm | N/A 2032-07-01 | Eloxx Pharmaceuticals Inc. | ELOX | Androski Lindsay Director | 40,000 | $0 | 40,000 (Direct) | View |